US hospital data show 30-day mortality rates for candidemia rose from 25% in 2015 to 32% in 2024.
Moderna has begun dosing participants in a phase 3 trial of its H5 pandemic flu vaccine candidate, mRNA-108.
A study in Canada found that nearly half of the solid-organ transplant patients who had Candida bloodstream infections died within 3 months.
Analysis of electronic health record data shows US aspergillosis diagnoses increased by more than 5% annually from 2013 through 2023.
State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.
Analysis of C auris clinical isolates by the CDC's Antimicrobial Resistance Laboratory Network finds that 95% were resistant to fluconazole and 15% to amphotericin B.
Histoplasmosis, blastomycosis, and coccidioidomycosis, which are often linked to contaminated soil, occur in different parts of the US.
Data from a new survey show Candida auris, which can cause deadly invasive infections, is spreading rapidly in European hospitals.
Data from 412 US hospitals from 2018 through 2023 show 4.5% of patients received an antifungal, a finding researchers say warrants a specific focus on antifungal stewardship.
Patients infected with the multidrug-resistant fungus were "characterized by significant underlying morbidity and disease burden," the study authors write.
